EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS

Buhl, R; Dreher, M; Mattiucci-Guehlke, M; Emerson-Stadler, R; Eckhardt, S; Taube, C; Vogelmeier, CF

Buhl, R (通讯作者)，Mainz Univ Hosp, Pulm Dept, Langenbeckstr 1, D-55131 Mainz, Germany.

ADVANCES IN THERAPY, 2023; 40 (7): 3263

Abstract

Introduction: The Global Initiative for Chronic Obstructive Lung Disease (GOLD 2023) no longer recommends a long-acting beta(2)-agonist (LABA) plus in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索